MRI scans are strong diagnostics with high-definition images of what lies inside a body. Strong magnetic fields require precaution, as brought out by an instance where a young woman suffered very serious injuries due to an oversight in a metallic core within a silicone sex toy that she happened to have before the MRI scan. This makes a stark reminder about the potentially deadly consequences of missing metal objects when such procedures are being performed. In April 2023, a 23-year-old woman went into an MRI with a silicone plug containing a metal core that was not known.
She thought that the item is made entirely out of silicone according to the advertising. However, the strong magnetic field of the MRI machine interacted with the hidden metal, dragging the object through her body and causing excruciating pain. According to reports from the U.S. Food and Drug Administration (FDA), the scene was harrowing, with the woman screaming in agony and requiring immediate hospitalization. Despite pre-scan screenings, which are routine prior to a scan, the patient did not inform the facility that the object existed because he presumed it was purely non-metallic. This caused serious injuries that led to the patient's law suit against the manufacturer for deceitful misrepresentations of material content.
MRI machines employ magnets between 0.5 to 3 Tesla (T). This is thousands of times stronger than the Earth's magnetic field. The tremendous force causes ferromagnetic materials, like iron and nickel, to be magnetized quickly and become strongly attracted toward the magnet. Objects as small as hairpins or paper clips will accelerate at 40 miles per hour inside the magnetic field.
The force can lead to catastrophic injuries in items lodged within the body, such as metallic implants or foreign objects. Metallic cores within devices, like pacemakers or intrauterine devices, must be disclosed to radiologists to prevent such complications.
On these claims, Dr. Adam Taylor, a specialist in human anatomy, weighed his words in a international health website and added that the distance away and mass of this object would increase its velocity towards that of sound, "The acceleration would be phenomenal, but with a metallic core, it can't go anywhere near supersonic speeds. As for the size, the magnetic acceleration to the internal soft tissues would ensure that there could be severe intracranial trauma."
The injuries inflicted in this case likely involved damage to major blood vessels, nerves, or organs, highlighting the devastating impact of even minor oversight during an MRI scan.
This is not an isolated case. There are documented cases of metallic objects causing serious damage during MRI scans with a 65-year-old man with schizophrenia swallowed metal objects, including sockets and a hinge pin. The powerful magnetic field during an MRI scan caused the objects to rupture his stomach, resulting in serious injuries.
A toddler who ingested 11 small magnets perforated his bowel while undergoing a scan, making his case unique. In another deadly but extremely rare incident, there have been people who hide a firearm on themselves during MRI procedures. Magnetic attraction can trigger a discharge in a weapon and has led to some fatal injuries.
These cases emphasize the very strong need for adequate screening and patient education prior to an MRI.
Medical professionals have been trained to avoid risks. This is by properly screening a patient for metallic objects. In general, most pre-scan protocols include:
The case emphasizes the importance of product labeling by manufacturers, especially those products that are likely to unintentionally cause harm to health. The patient's assumption that her device was 100% silicone points to a larger problem in consumer markets with misinformation.
It also reminds the patients to report any possible dangers to the medical professionals, no matter how the objects look non-metallic. In sensitive cases, patients can request private discussions with healthcare providers to ensure safety without discomfort.
In the end, it is a joint effort from manufacturers, healthcare professionals, and patients that can prevent such tragedies. Manufacturers must ensure truthful marketing, while healthcare providers should educate patients about the dangers of metal objects in MRI settings. For patients, understanding the risks and actively participating in pre-scan disclosures can be lifesaving.
This young woman's experience is a sobering example of the unforeseen dangers posed by MRI machines when precautions are overlooked. It serves as a wake-up call to address gaps in patient awareness, medical protocols, and product transparency. By learning from this incident, the medical community and the public can work together to ensure MRI scans remain a safe and effective diagnostic tool.
Credits: Istock
Ozempic 2.0: The arrival of Ozempic and similar GLP-1 drugs has already reshaped medicine and consumer behaviour in ways few anticipated. Millions of people have achieved weight loss at levels previously unseen, grocery companies are redesigning products with these users in mind, and insurers are studying how these drugs could influence long-term health and chronic disease. But as significant as this shift has been, the next wave of treatments may transform the field even further, according to the Washington Post.
A new generation of GLP-1 therapies is expected in the coming months, including daily pills, more potent injectables, and combination drugs that target multiple hormonal pathways. These options promise easier use, wider metabolic benefits, and in some cases results beyond what current medications offer. Experts caution that these drugs are still under review by regulators, yet anticipation is already high.
The first daily weight-loss pills may be approved as early as 2026. Novo Nordisk and Eli Lilly have developed oral versions of their popular drugs, providing an option for those who hesitate to self-inject or cannot afford refrigerated pens. Pills are also easier to distribute and could come with lower costs, potentially broadening access in regions where injectable GLP-1s remain expensive.
As per The Washington Post, early clinical trials show oral pills generally result in slightly less weight loss than injections. Participants typically shed around 11–14 percent of body weight over a year, compared with 15–20 percent for the most powerful injectables. Yet researchers believe that convenience, affordability, and broader insurance coverage could make daily pills a turning point for patients and the market alike.
Pharma companies are also working on injectables that stimulate multiple appetite-related hormones. Current GLP-1 drugs usually target one or two pathways, while Eli Lilly is testing a compound that acts on three. In mid-stage trials, participants on the highest dose lost more than 24 percent of their body weight in under a year—a result experts say comes close to the effectiveness of bariatric surgery.
As per The Washington Post, researchers note that outcomes may vary when larger and longer trials are completed. Regulators will need to assess safety carefully, especially regarding rapid weight loss or changes in muscle mass. Even so, specialists expect that patients with severe obesity may rely on these stronger options when they become available.
Nausea, digestive discomfort, and lean muscle loss remain common reasons patients stop current GLP-1 drugs. In response, companies are testing combinations aimed at delivering similar weight loss with fewer side effects. One promising approach pairs semaglutide—the compound behind Ozempic and Wegovy—with amylin. Early data suggests this combination can achieve roughly 20 percent weight loss with potentially less digestive strain.
Other research focuses on adjusting hormonal signals to preserve muscle. Trials combining multiple appetite-regulating pathways show encouraging reductions in fat while maintaining more lean tissue, which experts view as vital for long-term metabolic health.
Beyond pills and more potent weekly injectables, some companies are developing drugs that require only a single injection each month. If successful, these treatments could remove one of the biggest barriers for patients struggling with weekly dosing schedules.
Even as new treatments emerge, today’s GLP-1 drugs are unlikely to vanish. Years of safety data, approvals for reducing cardiovascular risk, and expanded use for conditions like sleep apnea give existing medications an edge that newcomers must match. Competition and shifting pricing structures are already pushing costs down, potentially making current options more attractive unless new alternatives clearly outperform them.
Still, the change underway is unmistakable. With multiple drug classes, delivery methods, and hormonal targets in development, the next five years could redefine medical weight loss, and who has access to it.
Credits: iStock, X, Nation Press
Just a day after GRAP-3 restrictions were removed from Delhi, the city's pollution levels worsened. The Commission for Air Quality Management (CAQM) lift the GRAP-3 restrictions on Thursday when Delhi recorded its average AQI at 377 at 4pm. However, by 8pm, the AQI as per the Central Pollution Control Board (CPCB)'s data was recorded at 381 by 8pm. Multiple stations also recorded "severe" range.
However, Delhi, as of 10am on Friday, 28 November, AQI was recorded 409, which is under "hazardous". In fact, as per the CPCB data, several areas like Anand Vihar and Burari Crossing, the AQI crossed 400, under 'severe' category, whereas areas like Mathura Road and Lodhi Road crossed 300, under 'very poor' category.
Also Read: How Post Malone Lost 55lbs Just By Cutting Soda And Ditching Junk
Amid Delhi's continuously worsening AQI, the Chief Justice of India, Surya Kant said that he cannot go out for his morning walk as it is causing him breathing issues. "The only exercise I do is walking. But even that is difficult now. Yesterday I walked for 55 minutes, and till morning I had problems,” the CJI said. Senior advocate Kapil Sibal also said that he has completely stopped going out for morning walks. "To breathe this obnoxious air...at out age..." he remarked. Earlier, Justice PS Narasimha warned lawyers about this "very, very serious" pollution levels and urged them to opt for virtual hearings to avoid health risks. "This pollution will cause permanent damage," he said.
However, CAQM believes that the pollution levels will improve by Friday. "Based on the forecast provided by the IMD and the Indian Institute of Tropical Meteorology, we were told the AQI will worsen marginally on Thursday as wind speeds will drop. However, by Thursday evening and from Friday onwards, winds are forecast to pick up again and so the AQI is not likely to touch 400 and into the severe category,” a CAQM official said.
Though experts do not agree. As per IIT Delhi professor Mukesh Khare, as reported in HT, says that even if AQI is improving, it "is likely to deteriorate again, so the decision to remove GRAP based on marginal improvement was illogical". "There is not much difference between an AQI of 320 and 350. We know conditions in winters are harsh and unpredictable and often unfavorable," he says.
Dr Rahul Chawla, a neurologist trained at AIIMS posted a video on his Instagram where he shared 5 ways to protect against Delhi's Air Pollution.
Dr Chawla suggested that one should stay indoors as much as possible. "You can open the windows and doors only between 1 and 3pm in the day, when you feel that the sun is bright, so that the house gets proper ventilation," he said.
Why 1pm to 3pm is the only time he suggests to have exposure with air? As per a 2023 study by an air filter brand, Delhi's air pollution peaked at 9AM and gradually improved as the day progressed. On an average, Delhi sees roughly as half as much PM2.5 by 5PM. Similarly, in Kolkata, the pollution peaks at 8am and is lowered by 4PM. This is why the safest time to have any sort of air exposure is in the afternoon. Pollution levels also tend to be slightly lower in the afternoon because it is when the sun is at its peak. This heats the ground and causes warm air to rise and mix with atmosphere. This helps disperse pollutants.
He also advised against cleaning inside the house using a dry cloth, and suggested wet cloth to be in use, so that dust does not rise. "Please do not light up things inside the house like burning dhoop (incense for worship), agarbatti (incense sticks), or anything else that causes excessive smoke,” he said.
“If there are elderly people at home, do not let them go for morning walks or evening walks, and if there are children, do not let them play in the park. Exercise at home. You can go up and down the stairs. You can do yoga. If you have a treadmill or a stationary bike at home, you can exercise with it. You can do weightlifting,” he said. However, he suggested that if going out is absolutely necessary, then one must wear N-95 mask properly before stepping out.
“If you can afford an air purifier, buy one. But keep in mind that the air purifier you are buying should be appropriate for the size of your room,” the neurologist advised.
The neurologist also suggested that if your company permits it, seek work from home option to reduce your exposure from toxic air.
Lastly, he suggested that if people can afford, and their profession allows, they must leave Delhi for a few weeks. “Because this city has become a gas chamber,” he warned.
Note: This article is not a medical advice and the information is derived from the video shared by the doctor. Please seek advice from your doctor before making any changes in your lifestyle.
Credits: iStock
The nation debate around vaccine has intensified in the US, and this week, it has taken a sharper turn as three separate developments have coincided in the country, all concerned with the administration of vaccines. Amid the controversial appointment of nation's top public health agency - the Centers for Disease Control and Prevention (CDC), and a major court ruling on school vaccine requirement in West Virginia, a third case of unvaccinated infant death is reported from Kentucky. The health officials confirm that the infant died of whooping cough, a vaccine preventable disease, which has reignited the debates around the use of vaccine.
While national debates continue, Kentucky is facing a direct and heartbreaking consequence of falling vaccination rates. Health officials have announced the death of another infant from whooping cough, bringing the total to three deaths in the past 12 months. The first two represented the state’s first pertussis deaths since 2018.
The Kentucky Department for Public Health did not disclose where the most recent death occurred. Officials expressed deep concern about the surge in cases and urged families to stay up to date on recommended vaccines. They stressed that vaccination protects not only individuals but also those who are too young or medically unable to be vaccinated.
As of November 19, Kentucky has recorded 566 pertussis cases this year. Infants under one year old face the highest risk of severe illness and death. The health department confirmed that none of the infants who died had been vaccinated, nor had their mothers received the recommended maternal pertussis shot during pregnancy.
Whooping cough begins with mild cold-like symptoms but can progress within weeks to violent coughing fits that make it hard for babies to breathe. Doctors warn that vaccination in pregnancy and infancy remains the most effective way to protect the youngest children.
The death of an unvaccinated child happened while anti-vaxxer Ralph Abraham, the former Louisiana surgeon general, was appointed as the new deputy director of the CDC. It has drawn immediate criticism. Abraham is now the second highest-ranking official at the agency, yet he has a long record of questioning mainstream vaccine guidance.
During the pandemic, Abraham openly supported the use of ivermectin, discouraged the birth dose of the hepatitis B vaccine and repeatedly criticized COVID-19 vaccines. While serving as Louisiana’s top health official, he instructed his department to stop promoting mass vaccination and stayed silent for two months during a pertussis outbreak that killed two infants earlier this year.
His appointment has alarmed public health experts, including his predecessor. Nirav Shah, who previously served as the CDC’s deputy director, told The New York Times that Abraham is not the right person for a role that involves leading emergency responses. Shah said that delaying public communication about infant pertussis deaths was unacceptable and called it shameful.
The debate over vaccine policy was further amplified after a judge in West Virginia ruled that the state must allow religious exemptions to its long-standing school immunization requirements. For decades, West Virginia has maintained one of the highest childhood vaccination rates in the country by permitting only medical exemptions.
Judge Michael E. Froble ruled that the policy violated the state’s religious freedom law, which was enacted two years ago. He said families who sought religious exemptions were being forced to choose between following their beliefs and accessing public education. His ruling now applies to all families who have previously requested religious exemptions.
The decision arrives at a time when measles and other vaccine-preventable illnesses are climbing nationwide. It also follows the appointment of Abraham to the CDC and ongoing remarks from Health Secretary Robert F. Kennedy Jr., who has repeatedly expressed skepticism about vaccine science. Together, these shifts are raising questions about how strongly the country’s health policies will hold in the coming years.
© 2024 Bennett, Coleman & Company Limited